Product Details
Priorix Tetra**
Measles, mumps, and rubella (MMR); Varicella vaccine0.5 mL
Powder for injection
ROA
Intramuscular; Subcutaneous
Applicant Name
Glaxo Smithkline Consumer Nigeria PLC
NRN
A6-0145
Status
Active
Composition
Measles, Mumps, Rubella and Varicella Vaccine (Live, Attenuated) After reconstitution, 1 dose (0.5 mL) contains: Live attenuated measles virus1 (Schwarz strain) NLT 10(3.0) CCID50(3), Live attenuated mumps virus1 (RIT 4385 strain, derived from Jeryl Lynn strain) NLT 10(4.4) CCID50(3), Live attenuated rubella virus2 (Wistar RA 27/3 strain) NLT 10(3.0) CCID50(3), Live attenuated varicella virus2 (OKA strain) NLT 10(3.3) PFU(4) 1) produced in chick embryo cells 2) produced in human diploid (MRC-5) cells 3) Cell Culture Infective Dose 50% 4) Plaque forming units Excipients: Amino acids, lactose, mannitol, sorbitol. Solvent is water for injections. Neomycin sulphate is present as a residual from the manufacturing process
ATC Code
Product Category
Vaccines and Biologics
Marketing Category
Prescription-only Medicine (POM)
Packsize
0.5 mL x 1's (in vial)
Product Description
Powder and solvent for solution for injection. The powder is white to slightly pink. The solvent is clear and colourless
Manufacturer Name
Glaxosmithkline Biologicals S.A
Manufacturer Country
BELGIUM
Approval Date
2024-02-28
Expiry Date
2029-02-27